218 related articles for article (PubMed ID: 26922774)
1. Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia.
Radivoyevitch T; Sachs RK; Gale RP; Smith MR; Hill BT
Leuk Res; 2016 Apr; 43():9-12. PubMed ID: 26922774
[TBL] [Abstract][Full Text] [Related]
2. Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?
Hamblin TJ
Leuk Res; 2008 Apr; 32(4):523-5. PubMed ID: 17915317
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of solid tumors in patients with chronic lymphocytic leukemia exposed to radiation after Chernobyl accident].
Ter Arkh; 2011; 83(10):18-22. PubMed ID: 22185019
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers.
Ojha J; Dyagil I; Finch SC; Reiss RF; de Smith AJ; Gonseth S; Zhou M; Hansen HM; Sherborne AL; Nakamura J; Bracci PM; Gudzenko N; Hatch M; Babkina N; Little MP; Chumak VV; Walsh KM; Bazyka D; Wiemels JL; Zablotska LB
Environ Health; 2018 May; 17(1):43. PubMed ID: 29720177
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels.
Schwartz GG; Klug MG
Future Oncol; 2016 Jan; 12(2):165-74. PubMed ID: 26515766
[TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation and cancer risk: evidence from epidemiology.
Ron E
Pediatr Radiol; 2002 Apr; 32(4):232-7; discussion 242-4. PubMed ID: 11956701
[No Abstract] [Full Text] [Related]
8. Ionizing radiation and cancer risk: evidence from epidemiology.
Ron E
Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
[TBL] [Abstract][Full Text] [Related]
9. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation.
Zablotska LB; Ashmore JP; Howe GR
Radiat Res; 2004 Jun; 161(6):633-41. PubMed ID: 15161357
[TBL] [Abstract][Full Text] [Related]
12. County level incidence rates of chronic lymphocytic leukemia are associated with residential radon levels.
Oancea SC; Rundquist BC; Simon I; Swartz S; Zheng Y; Zhou X; Sens MA; Schwartz GG
Future Oncol; 2017 Sep; 13(21):1873-1881. PubMed ID: 28835109
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers.
Vrijheid M; Cardis E; Ashmore P; Auvinen A; Gilbert E; Habib RR; Malker H; Muirhead CR; Richardson DB; Rogel A; Schubauer-Berigan M; Tardy H; Telle-Lamberton M;
Radiat Res; 2008 Nov; 170(5):661-5. PubMed ID: 18959468
[TBL] [Abstract][Full Text] [Related]
14. Distribution of rs2124594 genotypes in chronic lymphocytic leukemia patients depending on radiation anamnesis.
Bilous NI; Abramenko IV; Chumak AA; Diagil IS; Martina ZV
Probl Radiac Med Radiobiol; 2017 Dec; 22():323-331. PubMed ID: 29286517
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.
Linet MS; Schubauer-Berigan MK; Weisenburger DD; Richardson DB; Landgren O; Blair A; Silver S; Field RW; Caldwell G; Hatch M; Dores GM
Br J Haematol; 2007 Dec; 139(5):672-86. PubMed ID: 18021081
[TBL] [Abstract][Full Text] [Related]
16. The distribution of TP53 gene polymorphisms in chronic lymphocytic leukemia patients, sufferers of Chornobyl nuclear power plant accident.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2016 Dec; 38(4):252-256. PubMed ID: 28230820
[TBL] [Abstract][Full Text] [Related]
17. Ionizing radiation and chronic lymphocytic leukemia.
Richardson DB; Wing S; Schroeder J; Schmitz-Feuerhake I; Hoffmann W
Environ Health Perspect; 2005 Jan; 113(1):1-5. PubMed ID: 15626639
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
19. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
[TBL] [Abstract][Full Text] [Related]
20. Secondary lung tumors in hematological patients.
Amadori D; Ronconi S
Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
